
ShockWave Medical SWAV
Quarterly report 2024-Q1
added 05-06-2024
ShockWave Medical Total Assets 2011-2026 | SWAV
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.57 B | 646 M | 346 M | 272 M | 232 M | 53.4 M | 59.3 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.57 B | 53.4 M | 454 M |
Quarterly Total Assets ShockWave Medical
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.64 B | 1.47 B | 787 M | 783 M | 646 M | 476 M | 417 M | 373 M | 346 M | 299 M | 276 M | 269 M | 272 M | 272 M | 272 M | 272 M | 232 M | 232 M | 232 M | 232 M | 53.4 M | 53.4 M | 53.4 M | 53.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.64 B | 53.4 M | 417 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
6.21 B | $ 178.43 | 6.92 % | $ 13.4 B | ||
|
AxoGen
AXGN
|
222 M | $ 33.07 | 6.7 % | $ 1.52 B | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.23 | 1.71 % | $ 261 M | ||
|
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.22 | 2.3 % | $ 1.65 B | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
5.81 B | $ 38.3 | 4.45 % | $ 5.71 K | ||
|
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | ||
|
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.88 | 2.73 % | $ 1.14 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.61 | 2.95 % | $ 740 M | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
Inogen
INGN
|
299 M | $ 6.73 | -1.03 % | $ 179 M | ||
|
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.14 | 10.68 % | $ 19.3 M | ||
|
Integer Holdings Corporation
ITGR
|
3.41 B | $ 87.26 | 2.53 % | $ 3.03 B | ||
|
Electromed
ELMD
|
53.8 M | $ 24.45 | 2.82 % | $ 207 M | ||
|
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.95 | 1.21 % | $ 374 M | ||
|
Globus Medical
GMED
|
5.3 B | $ 91.99 | 2.21 % | $ 12.4 B | ||
|
LENSAR
LNSR
|
71.4 M | $ 5.6 | -0.53 % | $ 67 M | ||
|
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.36 | -1.29 % | $ 126 M | ||
|
Medtronic PLC
MDT
|
91.7 B | $ 88.34 | 2.22 % | $ 114 B | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Myomo
MYO
|
38.6 M | $ 0.68 | 0.03 % | $ 28.5 M | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
9.51 M | $ 2.73 | 2.62 % | $ 7.57 M | ||
|
Butterfly Network
BFLY
|
256 M | $ 4.15 | 2.47 % | $ 878 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | ||
|
Stryker Corporation
SYK
|
47.8 B | $ 338.41 | 1.91 % | $ 129 B | ||
|
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.62 | 1.66 % | $ 38.6 M | ||
|
Tactile Systems Technology
TCMD
|
274 M | $ 24.36 | 1.29 % | $ 557 M | ||
|
TransMedics Group
TMDX
|
1.07 B | $ 108.31 | 0.92 % | $ 3.68 B | ||
|
Tandem Diabetes Care
TNDM
|
881 M | $ 19.47 | 6.51 % | $ 1.32 B | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
124 M | $ 9.86 | 1.96 % | $ 353 M |